| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |